FLOHALE 0.5MG RESP
Out of Stock
Flohale 0.5mg Respules 2ml, manufactured by Cipla Ltd., is a prescription-grade inhaled corticosteroid formulated as a nebulization suspension containing Fluticasone Propionate at a concentration of 0.5mg per 2ml unit-dose respule. Designed for administration via a jet nebulizer, this clinical-grade solution targets the root immunological drivers of chronic airway inflammation in companion animals, most notably cats and dogs diagnosed with feline asthma, chronic bronchitis, or tracheobronchial inflammatory disease. Rather than addressing symptoms superficially, Flohale 0.5mg Respules works at the cellular level to suppress the inflammatory cascade responsible for persistent airway narrowing, excessive mucus production, and bronchospasm. Where systemic corticosteroids carry significant long-term risks, inhaled fluticasone propionate delivers potent anti-inflammatory action directly to the bronchopulmonary tissue while minimizing systemic exposure. Animeal is proud to offer Flohale 0.5mg Respules 2ml as part of its curated veterinary prescription catalogue, supporting pet parents and veterinary professionals in delivering cutting-edge respiratory care to their animal companions.
Ingredients:
Fluticasone Propionate:Fluticasone Propionate is a highly potent synthetic glucocorticoid (corticosteroid) belonging to the trifluorinated steroid class. Upon inhalation and nebulization into the lower airways, it exerts its action at the intracellular level by binding with exceptional affinity to cytosolic glucocorticoid receptors (GRs) located within bronchial epithelial cells, mast cells, eosinophils, macrophages, and dendritic cells. The resulting drug-receptor complex translocates into the cell nucleus, where it modulates transcription of pro-inflammatory genes by binding to glucocorticoid response elements (GREs) in the DNA.
